CAS 1610358-53-6 appears in our catalog under these names: (±)-Enitociclib/ 99.46% (existing batch purity), (±)–BAY–1251152, (±)-Enitociclib 98%, (±)-Enitociclib, 98%, 98%, (±)-Enitociclib, 99.23%. Offered by: TargetMol, GLPBio, Ambeed, Chemat, MedChemExpress. Available pack sizes: 1mg, 2mg, 5mg, 10mg, 25mg, 50mg, 100mg, 10mM (in 1ml dmso).
Enitociclib is a member of the class of aminopyridines that is pyridine substituted by {4-[(S-methylsulfonimidoyl)methyl]pyridin-2-yl}amino, 4-fluoro-2-methoxyphenyl, and fluoro groups at positions 2, 4, and 5, respectively. It is an inhibitor of cyclin-dependent kinase 9 that exhibits antineoplastic activity. It has a role as an antineoplastic agent and an EC 2.7.11.22 (cyclin-dependent kinase) inhibitor. It is a monomethoxybenzene, a sulfoximide, an aminopyridine, a biaryl and a member of monofluorobenzenes.
Source: ChEBI
| Molecular formula | C19H18F2N4O2S |
|---|---|
| Molecular weight | 404.4 g/mol |
| IUPAC name | 5-fluoro-4-(4-fluoro-2-methoxyphenyl)-N-[4-[(methylsulfonimidoyl)methyl]-2-pyridinyl]pyridin-2-amine |
| InChIKey | YZCUMZWULWOUMD-UHFFFAOYSA-N |
| SMILES | COC1=C(C=CC(=C1)F)C2=CC(=NC=C2F)NC3=NC=CC(=C3)CS(=N)(=O)C |
Computed by PubChem (NCBI)